Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
$731.4K
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
1108.24%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
$55.04M
Book Value
2026 Q1
$4.046M
Cash
2026 Q1
P/E
TTM
106.5
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $77.886 Million

About Starry Sea Acquisition Corp

Starry Sea Acquisition Corp (NASDAQ: SSEA) is a blank-check special purpose acquisition company (SPAC) incorporated in the Cayman Islands on December 5, 2024, that exists solely to identify and complete a merger or acquisition with a target business. The company generates no operating revenue. Its capital base consists of IPO proceeds held in a Trust Account, raised through the sale of 5,750,000 units at $10.00 per unit in an IPO declared effective August 7, 2025, and completed August 11, 2025. As of the 10-K filed April 2, 2026, the company had signed a Letter of Intent with Forever Young International Limited, a Cayman Islands company described as a health industry operator providing management and support services to medical institutions in China, at a contemplated pre-money equity value of $750 million to $900 million. CEO Yan Liang has served in the role since August 2025. The company's officers and directors have significant ties to China, and any completed business combination may be subject to PRC regulatory oversight including CAC cybersecurity review requirements.

Revenue model
No operating revenue. The SPAC model generates no recurring income. Capital is sourced from IPO proceeds held in trust, with working capital funded by amounts held outside the Trust Account. The intended monetization event is the consummation of an initial business combination.
Products and services
Blank-check acquisition vehicle. The sole activity is identifying, evaluating, and completing an initial business combination. As of the 10-K filed April 2, 2026, the company had a Letter of Intent with Forever Young International Limited targeting a health-services business combination.
Customers and end markets
No customers. The end market exposure post-combination, if completed, would be the China healthcare and medical institution management services sector, based on the Forever Young International Limited Letter of Intent disclosed in the FY2025 10-K.
Value-chain role
SPAC sponsor and acquisition vehicle. The company acts as a shell entity raising public capital to finance a private-to-public business combination transaction.
Geographic exposure
Incorporated in the Cayman Islands. Officers and directors have significant ties to China. The Letter of Intent target, Forever Young International Limited, operates in China. The company is listed on a U.S. exchange and files with the SEC.

Source: SEC 10-K, filed 2026-04-02

Industry: Blank Checks

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support